Bextra, Bextra!
07 september 2009
This week, the Dept. of Justice announced that Pfizer will pay $2.3B in civil and criminal penalties for off-label marketing of four drugs. The settlement, which alleges that off-label marketing tactics led to over-prescribing of Bextra, Lyrica, Geodon and Zyvox for unapproved indications, is the largest of its kind on record.
Bron: Prescription Project
| < Vorige | Volgende > |
|---|
